June 26, 2021
The founder of Corpometria Institute, Dr. Flavio Cadegiani, MD, MsC, PhD is a board certified Endocrinologist, with MsC and PhD degrees in Clinical Endocrinology at Federal University of São Paulo, and focused on investigations in the fields of hormonal physiology of athletic training, pathophysiology of Overtraining Syndrome, etiologies of fatigue, obesity, and androgens. Dr. Cadegiani has two concurrent careers, in the research and in private practice.
Currently Dr. Cadegiani has a position of CEO of Corpometria Institute and Clinical Director at Applied Biology. He obtained his medical degree in University of Brasilia in 2008, finished his residency in internal medicine in the same university in 2010 and fellowship in Endocrinology and Metabolism in HBDF, Brasilia, Brazil, in 2012. He obtained both master degree (MSc) and PhD in Clinical Endocrinology at Federal University of São Paulo (Unifesp/EPM), mentored by Prof. Dr. Cláudio Elias Kater
Dr. Cadegiani has become a worldwide expert in both Endocrinology and Sports Medicine fields, providing a unique endocrinological perspective from Physical Activity, in addition to a deeper understanding of the underlying mechanisms of fatigue. However, Dr. Cadegiani research fields go beyond fatigue and related conditions. He is a worldwide known expert for obesity management, perhaps amongst the largest experts in actual multidrug pharmacological weight loss management, and the creator and of the first protocol of a combination between pharmacological and non-pharmacological treat patients with moderate and severe obesity clinically and avoid bariatric surgery, and that has been scientifically demonstrated to be effective in the short and long terms.
Dr. Cadegiani contributions to the obesity field also include the first chapter fully dedicated to describe the dysfunctions of the liver in obesity and responses to bariatric surgery. He also described scientifically the first drug to reduce both early and late Dumping's syndrome that typically occurs after bariatric surgery, and he has now demonstrated paradoxical weight loss markers, including increase of homocysteine and triglycerides, which usually are considered as being negative parameters, but that was positivetely associated with fat loss.
Besides fatigue-related conditions, overtraining syndrome, endocrinology of physical activity, and obesity, Dr. Cadegiani believes that there is much to discover in the world of androgens and skin-related diseases, and how skin and hair can provide a deeper and more precise steroidal and metabolic mapping, particularly in the long term, in contrast to the snapchat sort of analysis of blood samples. He wants to expand the understanding of the multiple crosstalks between skin and hormones, and describe a thorough characterization of the peculiarities of the steroidal steroidogenesis in the hair and skin, as well as the implications for diagnoses and therapeutics.